Letter to the Editor

Abstract

Get full access to this article

View all access options for this article.

References

Horn HC , Grau K , Junker P. IVIG treatment for progressive stroke in the primary antiphospholipid antibody syndrome . Lupus 2004; 13: 478-480 .

Caplan LR. Stroke worsening - mechanisms and management. In Wahlgren NG , Ahmed N , Hardemark H-G eds. Update on stroke therapy 2002/2003. Stockholm: Karolinska Stroke Update , 2003: 221-227.

Reith J , Jorgensen HS , Pedersen PM et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome . Lancet 1996; 347: 422-425 .

Turner B , Wills AJ. Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome . J Neurol Neurosurg Psychiatry 2000; 68: 790-791 .

Katz KA , Hivnor CM , Geist DE , Shapiro M , Ming ME , Werth VP. Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions . Arch Dermatol 2003; 139: 991-993 .

Caress JB , Cartwright MS , Donofrio PD , Peacock JE, Jr. The clinical features of 16 cases of stroke associated with administration of IVIg . Neurology 2003; 60: 1822-1824 .

Okuda D , Flaster M , Frey J , Sivakumar K. Arterial thrombosis induced by IVIg and its treatment with tPA . Neurology 2003; 60: 1825-1826 .

Zaidan R , Al Moallem M , Wani BA et al. Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature . Eur J Neurol 2003; 10: 367-372 .

Vucic S , Chong PS , Dawson KT , Cudkowicz M , Cros D. Thromboembolic complications of intravenous immunoglobulin treatment . Eur Neurol 2004; 52: 141-144 .

10.

Jean R , Bastard E , Cretel E , Lefevre P , Durand JM. Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al . Arthritis Rheum 2004; 50: 2711-2713 .

11.

Reinhart WH , Berchtold PE. Effect of high-dose intravenous immunoglobulin therapy on blood rheology . Lancet 1992; 339: 662-664 .

12.

Dalakas MC , Clark WM. Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record . Neurology 2003; 60: 1736-1737 .

13.

Lapointe BM , Herx LM , Gill V , Metz LM , Kubes P. IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment . Brain 2004; 127: 2649-2656 .

14.

McCabe DJ , Harrison P , Mackie IJ et al. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack . Br J Haematol 2004; 125: 777-787 .

15.

Joseph JE , Donohoe S , Harrison P , Mackie IJ , Machin SJ. Platelet activation and turnover in the primary antiphospholipid syndrome . Lupus 1998; 7: 333-340 .

16.

Joseph JE , Harrison P , Mackie IJ , Isenberg DA , Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis . Br J Haematol 2001; 115: 451-459 .